KELSIE FOWLER: Open Payments
NPI 1770138562 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,248 in 223 payments from 19 companies in 2025. Trend: 2023 $3,633 · 2024 $4,037 · 2025 $3,248
Food & beverage: $3,248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $476 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 33 | $430 |
| Neurocrine BioSciences, Inc. | 24 | $304 |
| Axsome Therapeutics, Inc. | 18 | $257 |
| Janssen Pharmaceuticals, Inc | 17 | $254 |
| Alkermes, Inc. | 13 | $249 |
| Teva Pharmaceuticals USA, Inc. | 18 | $246 |
| Lundbeck LLC | 10 | $207 |
| Otsuka America Pharmaceutical, Inc. | 11 | $185 |
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, SPRAVATO, ARISTADA, COBENFY, Auvelity.
Industry payments across SC — which companies pay providers there.
